Ryan Alexander Jones - 11 Apr 2025 Form 4 Insider Report for Kyverna Therapeutics, Inc. (KYTX)

Role
Chief Financial Officer
Signature
By: /s/ Ryan Jones
Issuer symbol
KYTX
Transactions as of
11 Apr 2025
Net transactions value
$0
Form type
4
Filing time
15 Apr 2025, 17:42:36 UTC
Previous filing
29 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KYTX Common Stock Award $0 +12,000 +27% $0.000000 55,950 11 Apr 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KYTX Stock Option (right to buy) Award $0 +74,000 $0.000000 74,000 11 Apr 2024 Common Stock 74,000 $2.06 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit award of common stock, 1/4th of which shall vest on April 11, 2026, and 1/4th of which shall vest on each one-year anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
F2 1/4th of the shares subject to the option shall vest on April 11, 2026, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.